Respiratory virus activity from flu, COVID-19, and respiratory syncytial virus (RSV) continues to decline across most of the country, with only two jurisdictions—North Dakota and Wyoming—reporting high activity, the Centers for Disease Control and Prevention (CDC) said in updates today. ...
Hospitalizations continue to decline, but overall deaths were up slightly.
Amidst the anticipated increase in vaccine-preventable diseases as the global population ages, a first-of-its-kind study has underscored the dual benefits of adult immunization programs.
Activity from the three main respiratory viruses continues to decline in the United States, with one of the main flu markers—outpatient visits for flulike illness—now below the national baseline for the first time since October, the Centers for Disease Control and Prevention (CDC) said today in its latest updates for flu, COVID, and respiratory syncytial virus (RSV).
Respiratory virus activity in the United States is still elevated but continues to decline, with only 6 jurisdiction reporting high levels, down from 10 the previous week, the Centers for Disease Control and Prevention (CDC) said today in its data updates.
Experts say that focused planning and forecasting efforts helped avoid some of the worst-case scenarios. But there was still a significant number of severe outcomes, and there are still key areas of improvement – especially around vaccination.
